101 related articles for article (PubMed ID: 24937244)
1. Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics.
De Nayer A; Windhager E; Irmansyah ; Larmo I; Lindenbauer B; Rittmannsberger H; Platz T; Jones A; Whiteford J; Altman C
Int J Psychiatry Clin Pract; 2003; 7(1):59-66. PubMed ID: 24937244
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine demonstrates good tolerability and is associated with improvements in extrapyramidal symptoms in patients with schizophrenia switched from other antipsychotics: results of a naturalistic study.
Hellewell JS
Int J Psychiatry Clin Pract; 2007; 11(2):112-22. PubMed ID: 24937556
[TBL] [Abstract][Full Text] [Related]
3. An open multicentre pilot study examining the safety, efficacy and tolerability of fast titrated (800 mg/day by day 4) quetiapine in the treatment of schizophrenia/schizoaffective disorder.
Peuskens J; Devoitille JM; Kusters J; Vandenhoven G
Int J Psychiatry Clin Pract; 2008; 12(4):261-7. PubMed ID: 24937712
[TBL] [Abstract][Full Text] [Related]
4. Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia.
Ganesan S; Agambaram V; Randeree F; Eggens I; Huizar K; Meulien D;
Curr Med Res Opin; 2008 Jan; 24(1):21-32. PubMed ID: 18021496
[TBL] [Abstract][Full Text] [Related]
5. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
György B; Robert K; László C; Andrea J;
Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Buckley PF
Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
[TBL] [Abstract][Full Text] [Related]
7. The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia.
Chue P; Malla A; Bouchard RH; Lessard S; Ganesan S; Stip E; Johnson S; Chen E; Ahn YM; Kim YS; Robinson G; Schweikert C; Gendron A; Eriksson H;
Curr Med Res Opin; 2013 Mar; 29(3):227-39. PubMed ID: 23281876
[TBL] [Abstract][Full Text] [Related]
8. The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia.
Gibert J; Giner J; Bobes J; Tafalla M; Herranz S; Ovejero C; Rico-Villademoros F; For The Sos Group 1 ; Gibert J; Giner J; Bobes J; Tafalla M; Herranz S; Ovejero C; Rico-Villademoros F; For The Sos Group 1
Int J Psychiatry Clin Pract; 2007; 11(3):222-32. PubMed ID: 24941362
[TBL] [Abstract][Full Text] [Related]
9. Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents.
Kim EY; Chang SM; Shim JC; Joo EJ; Kim JJ; Kim YS; Ahn YM
Curr Med Res Opin; 2013 Oct; 29(10):1231-40. PubMed ID: 23777311
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.
Riedel M; Müller N; Spellmann I; Engel RR; Musil R; Valdevit R; Dehning S; Douhet A; Cerovecki A; Strassnig M; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2007 Oct; 257(7):402-12. PubMed ID: 17629725
[TBL] [Abstract][Full Text] [Related]
11. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].
Beszłej JA; Grzesiak M
Psychiatr Pol; 2005; 39(2):293-307. PubMed ID: 15881624
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
13. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.
Takekita Y; Kato M; Wakeno M; Sakai S; Suwa A; Nishida K; Okugawa G; Kinoshita T
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():110-4. PubMed ID: 23022672
[TBL] [Abstract][Full Text] [Related]
14. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
15. Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial.
Pae CU; Kim JJ; Lee CU; Lee SJ; Lee C; Patkar AA; Masand PS; Paik IH
J Clin Psychiatry; 2007 Mar; 68(3):399-405. PubMed ID: 17388709
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness, tolerability and subjective well-being in patients receiving quetiapine: findings of a post-marketing surveillance study in schizophrenia.
Lambert M; Reimitz PE; Naber D
Int J Psychiatry Clin Pract; 2006; 10(3):204-12. PubMed ID: 24941059
[TBL] [Abstract][Full Text] [Related]
17. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
18. Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia.
Weng J; Zhang Y; Li H; Shen Y; Yu W
Gen Psychiatr; 2019; 32(1):e100026. PubMed ID: 31179423
[TBL] [Abstract][Full Text] [Related]
19. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study.
Hashimoto N; Toyomaki A; Honda M; Miyano S; Nitta N; Sawayama H; Sugawara Y; Uemura K; Tsukamoto N; Koyama T; Kusumi I
Ann Gen Psychiatry; 2015; 14(1):1. PubMed ID: 25632293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
